<DOC>
	<DOC>NCT01001702</DOC>
	<brief_summary>The purpose of this study is to test the long-term safety and tolerability of oral aripiprazole in adolescent patients with schizophrenia.</brief_summary>
	<brief_title>Oral Aripiprazole Open-Label Rollover Study</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Subjects with a confirmed Axis I Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSMIV) diagnosis of schizophrenia who must have completed Otsuka study 3103241 (NCT00102518) treatment of adolescent subjects with schizophrenia Patients with a comorbid serious, uncontrolled systemic illness Patients with a significant risk of committing suicide</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Open Label</keyword>
	<keyword>Aripiprazole</keyword>
</DOC>